<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03532633</url>
  </required_header>
  <id_info>
    <org_study_id>NEO-MICRO</org_study_id>
    <nct_id>NCT03532633</nct_id>
  </id_info>
  <brief_title>Supply With Micornutrients (Purine and Pyrimidine) in Infants: a Prospective and Observational Study</brief_title>
  <official_title>Beobachtungsstudie Zur Versorgung Reif- Und Frühgeborener Mit ausgewählten Mikronährstoffen Wissenschaftliche Untersuchung Bei Minderjährigen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Concentrations of micronutrients (especially purine and pyrimidine) in cord blood, blood of
      mothers and infants and human milk is studied
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Collection of:

        1. cord plasma in preterm and term infants.

        2. remnants of clinically indicated blood samples of mothers 24 hours before or after
           birth.

        3. remnants of clinically indicated blood samples of preterm and term infants during
           neonatal care.

        4. breast milk once a weak during neonatal care of the infant.

      Determination concentrations of micronutrients by mass spectrometry.

      Aim is to compare cord plasma concentrations with postnatal plasma concentrations and to
      measure concentrations in breast milk to determine the actual supply.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Concentration of purine and pyrimidine in cord plasma</measure>
    <time_frame>at birth</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Concentration of purine and pyrimidine in neonatal plasma</measure>
    <time_frame>at times when a clinically indicated blood sample is taken before discharge home from the initial neonatal hospitalization (at a postnatal age of up to 4-5 months at the most in very preterm infants)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of purine and pyrimidine in breast milk</measure>
    <time_frame>once a week before discharge home from the initial neonatal hospitalization, maximum 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of purine and pyrimidine in plasma of mothers</measure>
    <time_frame>24 hours before and after birth</time_frame>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Prematurity</condition>
  <arm_group>
    <arm_group_label>23-27w</arm_group_label>
    <description>preterm infants 23+0-27+6SSW</description>
  </arm_group>
  <arm_group>
    <arm_group_label>28-31w</arm_group_label>
    <description>preterm infants 28+0-31+6SSW</description>
  </arm_group>
  <arm_group>
    <arm_group_label>32-34w</arm_group_label>
    <description>preterm infants 32+0 - 34+6SSW</description>
  </arm_group>
  <arm_group>
    <arm_group_label>35-36w</arm_group_label>
    <description>preterm infants 35+0-36+6 SSW</description>
  </arm_group>
  <arm_group>
    <arm_group_label>37-42w</arm_group_label>
    <description>term infants 37+0-42+6</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cord blood</intervention_name>
    <description>collection of cord blood</description>
    <arm_group_label>23-27w</arm_group_label>
    <arm_group_label>28-31w</arm_group_label>
    <arm_group_label>32-34w</arm_group_label>
    <arm_group_label>35-36w</arm_group_label>
    <arm_group_label>37-42w</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blood sample infant</intervention_name>
    <description>collection of remnant of clinically indicated blood sample</description>
    <arm_group_label>23-27w</arm_group_label>
    <arm_group_label>28-31w</arm_group_label>
    <arm_group_label>32-34w</arm_group_label>
    <arm_group_label>35-36w</arm_group_label>
    <arm_group_label>37-42w</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blood sample mother</intervention_name>
    <description>collection of remnant of clinically indicated blood sample. If not available blood sample is taken after mother agreed</description>
    <arm_group_label>23-27w</arm_group_label>
    <arm_group_label>28-31w</arm_group_label>
    <arm_group_label>32-34w</arm_group_label>
    <arm_group_label>35-36w</arm_group_label>
    <arm_group_label>37-42w</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>breast milk</intervention_name>
    <description>collection of breast milk 1/week during neonatal care (maximum 8 weaks)</description>
    <arm_group_label>23-27w</arm_group_label>
    <arm_group_label>28-31w</arm_group_label>
    <arm_group_label>32-34w</arm_group_label>
    <arm_group_label>35-36w</arm_group_label>
    <arm_group_label>37-42w</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        infants and preterm infants
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  23+0-42+6 SSW

        Exclusion Criteria:

          -  congenital malformation, genetic disorders

          -  metabolic disease of the infant

          -  missing agreement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Franz</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Tuebingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katrin Böckmann</last_name>
    <phone>+49707129</phone>
    <phone_ext>82621</phone_ext>
    <email>katrin.a.boeckmann@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Axel Franz</last_name>
    <phone>+49707129</phone>
    <phone_ext>83791</phone_ext>
    <email>axel.franz@med.uni-tuebingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Children's Hospital Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Franz, MD</last_name>
      <phone>+497071290</phone>
      <email>axel.franz@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Axel Franz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2018</study_first_submitted>
  <study_first_submitted_qc>May 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2018</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>infant</keyword>
  <keyword>cord</keyword>
  <keyword>micronutrients</keyword>
  <keyword>purine</keyword>
  <keyword>pyrimidine</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

